Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_3
1
20%
Ph phase_4
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)

Trials by Status

active_not_recruiting120%
unknown240%
completed240%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingphase_3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

NCT05627557
unknownphase_2

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

NCT05298683
completedphase_4

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

NCT02180334
completedphase_2

Analgesic Effect of IV Acetaminophen in Tonsillectomies

NCT01691690
unknownphase_4

The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau

NCT00137566

Clinical Trials (5)

Showing 5 of 5 trials
NCT05627557Phase 3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

Active Not Recruiting
NCT05298683Phase 2

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Unknown
NCT02180334Phase 4

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Completed
NCT01691690Phase 2

Analgesic Effect of IV Acetaminophen in Tonsillectomies

Completed
NCT00137566Phase 4

The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5